ACAT2
protein-codingacetyl-CoA acetyltransferase 2
Gene summary
The product of this gene is an enzyme involved in lipid metabolism, and it encodes cytosolic acetoacetyl-CoA thiolase. This gene shows complementary overlapping with the 3-prime region of the TCP1 gene in both mouse and human. These genes are encoded on opposite strands of DNA, as well as in opposite transcriptional orientation. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2014]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~17.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013548
Submitter: Ambry Genetics
Inheritance Pattern: Unknown
Disease ID:MONDO:0013548
Submitter: ClinGen
No convincing evidence for a causal role for ACAT2 in acetyl-CoA acetyltransferase-2 deficiency has been reported. Two patients proposed to be affected with this disease have been reported (PMID: 6150136 and PMID: 20597). However, they were never investigated genetically, and later reviews highlight the incomplete and unproven nature of this diagnosis due to the evaluation of the enzyme only (PMID: 9607396). Although this gene-disease association is supported by its biochemical function and an animal model with preweaning lethality (PMID: 27626380), no reports have directly implicated the gene in humans. This gene-disease pair was originally evaluated by the FAO GCEP on 08/14/2018. It was reevaluated on 01/15/2021. As a result of this reevaluation, the classification did not change as no new information is contributing to the classification.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ACAT2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_005891.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 3 | 1 | 5 | ||
| missense | 58 | 3 | 1 | 62 | ||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 0 | 0 | 61 | 6 | 2 | 69 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_005882.2 | 9 | MANE Select | |
| Ensembl | ENSP00000356015.4 | 9 | MANE Select | |
| RefSeq | NP_001290182.1 | 9 | Standard | |
| Ensembl | ENSP00000539640.1 | 9 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Mevalonate pathway
- Tryptophan metabolism - Homo sapiens (human)
- Pyruvate metabolism - Homo sapiens (human)
- Butanoate metabolism - Homo sapiens (human)
- Fat digestion and absorption - Homo sapiens (human)
Biological Process
- lipid metabolic process
- fatty acid beta-oxidation
- cholesterol biosynthetic process
Molecular Function
- acetyl-CoA C-acetyltransferase activity
- acetyl-CoA C-acyltransferase activity
- protein binding
Cellular Component
- nucleus
- nucleolus
- cytoplasm
- mitochondrion
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000367048
- Coding exons
- 9
- Length
- 18785
- Individuals with no LoFs
- 125709
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 39
- Defined
- 125748
- p
- 0.000155
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.699 | 190 | 219 | 0.867 | 0.0000104 | 2561 |
| Missense (PolyPhen) | 57 | 87.792 | 0.64926 | 1046 | ||
| Synonymous | 0.418 | 68 | 72.5 | 0.938 | 0.00000331 | 817 |
| Loss of Function | 1.12 | 12 | 17.0 | 0.706 | 7.82e-7 | 218 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000058 | 0.000058 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00025 | 0.00025 | rare |
| South Asian | 0.00020 | 0.00020 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
Recessive Scores
- pRec
- 0.259
Intolerance Scores
- LoFtool
- 0.537
- RVIS EVS
- -0.36
- RVIS percentile EVS
- 28.93
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.348
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |